홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diisopropylethylamine → 7-[(1-methylethyl)oxy]-6-(methylsulfonyl)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-N-[(1R)-2,2,2-trifluoro-1-phenylethyl]-4-quinolinecarboxamide

HRID 245188
인쇄

반응식

HRID 245188 반응식
[CH3:1][CH:2]([O:4][C:5]1[CH:14]=[C:13]2[C:8]([C:9]([C:38]([OH:40])=O)=[C:10]([CH2:25][N:26]3[CH2:31][CH2:30][CH:29]([N:32]4[CH2:37][CH2:36][O:35][CH2:34][CH2:33]4)[CH2:28][CH2:27]3)[C:11]([C:15]3[CH:20]=[CH:19][CH:18]=[C:17]([C:21]([F:24])([F:23])[F:22])[CH:16]=3)=[N:12]2)=[CH:7][C:6]=1[S:41]([CH3:44])(=[O:43])=[O:42])[CH3:3].[F:45][C:46]([F:56])([F:55])[C@@H:47]([C:49]1[CH:54]=[CH:53][CH:52]=[CH:51][CH:50]=1)[NH2:48].C(N(CC)C(C)C)(C)C.C(P1(=O)OP(=O)(CCC)OP(=O)(CCC)O1)CC>C(OCC)(=O)C.ClCCl.C([O-])(O)=O.[Na+]>[CH3:3][CH:2]([O:4][C:5]1[CH:14]=[C:13]2[C:8]([C:9]([C:38]([NH:48][C@H:47]([C:49]3[CH:54]=[CH:53][CH:52]=[CH:51][CH:50]=3)[C:46]([F:45])([F:55])[F:56])=[O:40])=[C:10]([CH2:25][N:26]3[CH2:27][CH2:28][CH:29]([N:32]4[CH2:37][CH2:36][O:35][CH2:34][CH2:33]4)[CH2:30][CH2:31]3)[C:11]([C:15]3[CH:20]=[CH:19][CH:18]=[C:17]([C:21]([F:24])([F:23])[F:22])[CH:16]=3)=[N:12]2)=[CH:7][C:6]=1[S:41]([CH3:44])(=[O:42])=[O:43])[CH3:1]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 81531DiisopropylethylamineHCID 111923Propylphosphonic anhydrideHCID 11789718(alphaR)-alpha-(Trifluoromethyl)benzenemethanamineHCID 674183557-[(1-Methylethyl)oxy]-6-(methylsulfonyl)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylic acid

생성물 1

HCID 53476331
7-[(1-methylethyl)oxy]-6-(methylsulfonyl)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-N-[(1R)-2,2,2-trifluoro-1-phenylethyl]-4-quinolinecarboxamide
수율 54.9%

시약·촉매·용매 3

HCID 6344Dichloromethane용매HCID 8857Ethyl Acetate용매HCID 516892Sodium Bicarbonate용매

실험 절차

A solution of 7-[(1-methylethyl)oxy]-6-(methylsulfonyl)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylic acid (0.200 mg, 0.315 mmol), (1R)-2,2,2-trifluoro-1-phenylethanamine (0.072 g, 0.409 mmol), N,N-diisopropylethylamine (10.99 μL, 0.063 mmol), and 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane 2,4,6-trioxide (0.262 mL of a 50% solution in ethyl acetate, 0.440 mmol) in dichloromethane (2 mL) was stirred at 0° C. for 2 h. The solution was warmed to room temperature overnight, diluted with saturated aqueous NaHCO3, and extracted with methylene chloride (three times). The combined organic extracts were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. The residue was purified via HPLC (Waters, Sunfire 30×100 mm, 25-60% CH3CN/H2O with 0.1% TFA) to afford 7-[(1-methylethyl)oxy]-6-(methylsulfonyl)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-N-[(1R)-2,2,2-trifluoro-1-phenylethyl]-4-quinolinecarboxamide (0.137 g, 52% yield). 1H NMR (400 MHz, CHLOROFORM-d) δ9.85 (br. s., 1H), 8.79 (s, 1H), 7.81 (s, 1H), 7.75-7.80 (m, 1H), 7.64-7.69 (m, 2H), 7.52-7.59 (m, 3H), 7.42-7.48 (m, 3H), 6.25 (t, J=6.90 Hz, 1H), 4.91 (dt, J=6.02, 12.05 Hz, 1H), 3.65-3.72 (m, 5H), 3.52-3.65 (m, 2H), 3.31 (s, 3H), 2.64 (br. s., 1H), 2.38-2.45 (m, 4H), 2.20 (br. s., 1H), 2.03 (t, J=10.67 Hz, 1H), 1.66 (br. s., 4H), 1.59 (d, J=11.54 Hz, 2H), 1.54 (s, 3H), 1.53 (s, 3H); MS (m/z) 793.3 (M+H+).

후처리

  1. extractionextracted with methylene chloride (three times)
  2. washThe combined organic extracts were washed with brine
  3. dry with materialdried over Na2SO4
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. customThe residue was purified via HPLC (Waters, Sunfire 30×100 mm, 25-60% CH3CN/H2O with 0.1% TFA)

출처 및 근거

ORD 기록
ord-ccfb70949b5a4d9eab42dd083e6d4bc9
출처 데이터셋
uspto-grants-2014_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08658636B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트